Latest Whitepapers

Whitepaper
The End of End-Point Assays
This whitepaper highlights the recent developments and performance of three modular benchtop solutions for the high-performance quantitation and kinetics characterization of proteins and their small molecule interactions.

Whitepaper
Streamlining Affinity Analysis for Accelerated Drug Discovery
This whitepaper highlights the features and capabilities of a novel system for streamlining affinity analysis for rapid lead molecule screening.

Whitepaper
How Spatial Phenotyping Can Uncover Novel Insights in Tissue Biology
Rather than choosing between the detail of single-cell RNA sequencing and the in situ capabilities of conventional immunohistochemistry, spatial phenotyping allow you to visualize and quantify dozens of biomarkers in a single tissue sample while maintaining cellular and sub-cellular detail.

Whitepaper
Investigating Cell-Free DNA in Liquid Biopsy
Only a small amount of cell-free DNA (cfDNA) can be found in circulation, therefore efficient and highly sensitive technologies such as next-generation sequencing (NGS) are typically being used to detect this biomarker.

Whitepaper
Therapies Targeting Myeloid-Derived Suppressor Cells in the Tumor Microenvironment
Studying the tumor microenvironment (TME) helps improve our understanding of cancer. Myeloid-derived suppressor cells (MDSCs) exist within the TME and maintain cancer progression.

Whitepaper
An Optimized Workflow for Generating Anti-CD19 CAR T Cells by mRNA Electroporation
Chimeric antigen receptor (CAR) T-cell therapy is a revolutionary and promising approach for cancer treatment. However, its potential is limited by technical challenges and safety risks associated with viral transduction–based CAR T-cell generation workflows.

Whitepaper
Accelerating Cancer Research Through Comprehensive Genomic Analysis
While next-generation sequencing is becoming increasingly routine in cancer research laboratories, it fails to address a number of key genomic drivers or markers of cancer, such as structural variations, DNA methylation and transcript isoforms.

Whitepaper
PD-1/PD-L1 Combination Therapy in Cancer Treatment
Cancer immunotherapy, especially the use of immune checkpoint inhibitors, has been successful in improving the treatment landscape of malignancies.

Whitepaper
High-Throughput, Multi-Parametric Analysis Accelerates Antibody Discovery Workflows
Download this whitepaper to discover how high-throughput flow cytometry can provide quantitative data on binding, antibody internalization and antibody-dependent cell-mediated cytotoxicity, antibody-dependent cellular phagocytosis and T-cell activation.

Whitepaper
Streamline Antibody Labeling Workflows
Primary antibody labeling simplifies assays, enables multiplexing and eliminates the cross-reactivity seen with secondary antibodies – helping you to streamline your workflow, increase your flexibility and improve reproducibility.
Advertisement